15 Patents
- US124930472025Cleaved High Molecule Weight Kininogen (HMWK) Antibodies and Methods of Using
Takeda Pharmaceutical Company Limited
0 cites - 0 cites
- US124545752025Nucleic Acids Encoding Fcrn-binding Antibodies, Pharmaceutical Compositions Thereof and Methods of Use Thereof to Make Antibodies
Takeda Pharmaceutical Company Limited
0 cites - US124428242025Assays for Determining Plasma Kallikrein System Biomarkers
Takeda Pharmaceutical Company Limited
0 cites - 0 cites
- US123848542025Plasma Kallikrein Binding Proteins and Uses Thereof in Treating Hereditary Angioedema
Takeda Pharmaceutical Company Limited
0 cites - US121889482025Metabolite Biomarkers for Diseases Associated with the Contact Activation System
Takeda Pharmaceutical Company Limited
0 cites - US121353292024Peptide Quantitation Assay for Differentiating Full-length High Molecular Weight Kininogen (HMWK) and Cleaved HMWK
Takeda Pharmaceutical Company Limited
0 cites - US120845152024Compositions and Methods for Treatment of Diabetic Macular Edema
Takeda Pharmaceutical Company Limited
0 cites - 0 cites
- 0 cites
- US118267582023Evacuated Blood Collection Tubes Containing Protease Inhibitors for the Assessment of Contact System Activation
Takeda Pharmaceutical Company Limited
0 cites - US118155162023Protein Biomarkers for Diseases Associated with the Contact Activation System
Takeda Pharmaceutical Company Limited
0 cites - 0 cites
- US116687182023Peptide Quantitation Assay for Differentiating Full-length High Molecular Weight Kininogen (HMWK) and Cleaved HMWK
Takeda Pharmaceutical Company Limited
0 cites